Reference
Hossain MS, et al. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme. Infectious Diseases of Poverty 7: 80, No. 1, 13 Aug 2018. Available from: URL: http://doi.org/10.1186/s40249-018-0461-0 - Bangladesh
Rights and permissions
About this article
Cite this article
Amphotericin-b-liposomal/miltefosine. Reactions Weekly 1718, 27 (2018). https://doi.org/10.1007/s40278-018-51371-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-51371-9